TD Asset Management
RMD icon

TD Asset Management’s ResMed RMD Stock Holding History

TD Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Sell
55,042
-36,364
-40% -$7.54M 0.01% 639
2026
Q1 		$20.5M Buy
91,406
+5,744
+7% +$1.43M 0.02% 500
2025
Q4 		$20.6M Buy
85,662
+9,256
+12% +$2.37M 0.02% 507
2025
Q3 		$20.9M Sell
76,406
-1,733
-2% -$473K 0.02% 502
2025
Q2 		$20.2M Sell
78,139
-416
-0.5% -$99.2K 0.02% 493
2025
Q1 		$17.6M Buy
78,555
+196
+0.3% +$45.8K 0.02% 523
2024
Q4 		$17.9M Sell
78,359
-23
-0% -$5.54K 0.02% 529
2024
Q3 		$18.7M Buy
78,382
+908
+1% +$203K 0.02% 521
2024
Q2 		$14.8M Buy
77,474
+9,930
+15% +$2.01M 0.01% 554
2024
Q1 		$13.4M Buy
67,544
+16,246
+32% +$2.98M 0.01% 573
2023
Q4 		$8.82M Buy
51,298
+4,441
+9% +$682K 0.01% 641
2023
Q3 		$6.93M Sell
46,857
-2,024
-4% -$366K 0.01% 659
2023
Q2 		$10.7M Sell
48,881
-11,188
-19% -$2.49M 0.01% 585
2023
Q1 		$13.2M Sell
60,069
-5,110
-8% -$1.11M 0.02% 533
2022
Q4 		$13.6M Sell
65,179
-11,029
-14% -$2.42M 0.02% 526
2022
Q3 		$16.6M Sell
76,208
-6,875
-8% -$1.56M 0.02% 461
2022
Q2 		$17.4M Sell
83,083
-5,816
-7% -$1.24M 0.02% 463
2022
Q1 		$21.6M Sell
88,899
-27,164
-23% -$6.57M 0.02% 459
2021
Q4 		$30.2M Buy
116,063
+27,001
+30% +$7.01M 0.03% 410
2021
Q3 		$23.5M Buy
89,062
+15,200
+21% +$4.16M 0.02% 435
2021
Q2 		$20.1M Buy
73,862
+10,183
+16% +$2.14M 0.02% 480
2021
Q1 		$12.4M Buy
63,679
+8,016
+14% +$1.61M 0.01% 589
2020
Q4 		$11.8M Buy
55,663
+5,533
+11% +$1.1M 0.01% 539
2020
Q3 		$8.59M Buy
50,130
+5,179
+12% +$956K 0.01% 581
2020
Q2 		$8.63M Buy
44,951
+9,332
+26% +$1.53M 0.01% 545
2020
Q1 		$5.25M Buy
35,619
+700
+2% +$111K 0.01% 610
2019
Q4 		$5.41M Sell
34,919
-29,200
-46% -$4.21M 0.01% 692
2019
Q3 		$8.66M Sell
64,119
-86,760
-58% -$11.4M 0.01% 561
2019
Q2 		$18.4M Sell
150,879
-10,458
-6% -$1.16M 0.03% 393
2019
Q1 		$16.8M Buy
161,337
+28,700
+22% +$2.96M 0.03% 395
2018
Q4 		$15.1M Buy
132,637
+68,910
+108% +$7.38M 0.03% 401
2018
Q3 		$7.35M Buy
63,727
+20,218
+46% +$2.21M 0.01% 616
2018
Q2 		$4.51M Buy
43,509
+2,990
+7% +$303K 0.01% 740
2018
Q1 		$3.99M Sell
40,519
-1,283
-3% -$121K 0.01% 726
2017
Q4 		$3.54M Sell
41,802
-1,822
-4% -$151K 0.01% 758
2017
Q3 		$3.36M Buy
43,624
+40,532
+1,311% +$3.1M 0.01% 758
2017
Q2 		$241K Sell
3,092
-5,537
-64% -$396K ﹤0.01% 1290
2017
Q1 		$621K Buy
8,629
+420
+5% +$29K ﹤0.01% 1158
2016
Q4 		$509K Buy
8,209
+66
+0.8% +$4.04K ﹤0.01% 1178
2016
Q3 		$528K Sell
8,143
-2,300
-22% -$153K ﹤0.01% 1174
2016
Q2 		$660K Buy
10,443
+1,900
+22% +$112K ﹤0.01% 1040
2016
Q1 		$494K Sell
8,543
-1,700
-17% -$96.2K ﹤0.01% 1101
2015
Q4 		$550K Buy
10,243
+4,700
+85% +$265K ﹤0.01% 1081
2015
Q3 		$282K Sell
5,543
-16,400
-75% -$883K ﹤0.01% 1210
2015
Q2 		$1.24M Sell
21,943
-22,500
-51% -$1.42M ﹤0.01% 924
2015
Q1 		$3.19M Buy
44,443
+4,943
+13% +$321K 0.01% 769
2014
Q4 		$2.21M Buy
39,500
+8,500
+27% +$444K ﹤0.01% 827
2014
Q3 		$1.53M Buy
31,000
+11,000
+55% +$560K ﹤0.01% 860
2014
Q2 		$1.01M Buy
20,000
+6,700
+50% +$332K ﹤0.01% 903
2014
Q1 		$594K Buy
13,300
+4,300
+48% +$193K ﹤0.01% 997
2013
Q4 		$424K Buy
9,000
+3,900
+76% +$197K ﹤0.01% 1061
2013
Q3 		$269K Buy
+5,100
New +$247K ﹤0.01% 1140

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

TD Asset Management's RMD Position: Q2 2026 in Review

TD Asset Management reduced its ResMed (RMD) stake by 40% in Q2 2026, selling an estimated $7.54M and leaving 55,042 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #639.

TD Asset Management first reported a position in RMD in Q3 2013 and has held it in 52 quarters since. The position peaked at $30.2M in Q4 2021. 707 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • TD Asset Management held 55,042 shares of ResMed worth $10.7M as of Q2 2026.
  • TD Asset Management sold 36,364 ResMed shares in Q2 2026, an estimated $7.54M.
  • ResMed made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #639 holding.
  • TD Asset Management first reported a position in ResMed in Q3 2013 and has held it in 52 quarters since.
  • TD Asset Management's ResMed position peaked at $30.2M in Q4 2021.
  • 707 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.